scispace - formally typeset
C

Cathy S. Berkman

Researcher at Fordham University

Publications -  29
Citations -  1730

Cathy S. Berkman is an academic researcher from Fordham University. The author has contributed to research in topics: Palliative care & Health care. The author has an hindex of 13, co-authored 25 publications receiving 1623 citations. Previous affiliations of Cathy S. Berkman include Yale University.

Papers
More filters
Journal ArticleDOI

Depressive symptoms in relation to physical health and functioning in the elderly

TL;DR: The authors conclude that physical disabilities among the elderly do not appear to be a major threat to the validity of the CES-D scale and that the strong associations between physical and mental health should be rigorously investigated.
Journal ArticleDOI

Homophobia and Heterosexism in Social Workers

TL;DR: The study attempted to measure the extent of homophobia and heterosexist bias and their correlates in a cohort of 187 social workers using the Index of Attitude toward Homosexuality, the Attitudes toward Lesbians and Gay Men Scales, and a newly created scale to measure heteroseXist bias.
Journal ArticleDOI

The Relationship among Income, other Socioeconomic Indicators, and Functional Level in Older Persons

TL;DR: The association between income and function was seen throughout the full gradient of income and remained significant when controlling for age, gender, race/ethnicity, household size, education, occupation, age of immigration, and locus of control.
Journal ArticleDOI

Assessing medical students' training in end-of-life communication: a survey of interns at one urban teaching hospital.

TL;DR: These interns, mostly U.S. medical school graduates, reported little training and low self-perceived comfort and skill with important elements of end-of-life communication that might contribute to a lack of preparedness to address these issues during their internship.
Journal ArticleDOI

Use of Alternative Treatments by People with Multiple Sclerosis

TL;DR: The prevalence of the use of specific alternative treatments by people with MS, the sociodemographic and disease characteristics of those most likely to use alternative treatments, perceived benefits and harms from use of these treatments, and the reasons for their use are described.